S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: Tiny biotech successfully treats blindness (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
BREAKING: Tiny biotech successfully treats blindness (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: Tiny biotech successfully treats blindness (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
BREAKING: Tiny biotech successfully treats blindness (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: Tiny biotech successfully treats blindness (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
BREAKING: Tiny biotech successfully treats blindness (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: Tiny biotech successfully treats blindness (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
BREAKING: Tiny biotech successfully treats blindness (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
OTCMKTS:TCNNF

Trulieve Cannabis (TCNNF) Stock Forecast, Price & News

$6.09
-0.12 (-1.93%)
(As of 09/29/2023 ET)
Compare
Today's Range
$6.05
$6.40
50-Day Range
$3.45
$7.45
52-Week Range
$3.42
$16.11
Volume
247,786 shs
Average Volume
385,710 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$43.33

TCNNF stock logo

About Trulieve Cannabis (OTCMKTS:TCNNF) Stock

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. It produces flowers, edibles, vaporizer cartridge, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, California, Maryland, Massachusetts, West Virginia, and Connecticut; and affiliated dispensaries in Pennsylvania. It also operated cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Massachusetts, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.

TCNNF Price History

TCNNF Stock News Headlines

Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Elon Did It Again: This Could be Bigger than Tesla
Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.
Trulieve Announces September 2023 Event Participation
Trulieve Q2 Revenue Declines 10% YoY, What About Adjusted EBITDA?
See More Headlines
Receive TCNNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trulieve Cannabis and its competitors with MarketBeat's FREE daily newsletter.

TCNNF Company Calendar

Last Earnings
11/15/2021
Today
10/01/2023
Next Earnings (Estimated)
11/07/2023

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TCNNF
Fax
N/A
Employees
5,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$43.33
High Stock Price Forecast
$132.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+611.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ms. Kimberly Rivers (Age 45)
    Founder, Chairman & CEO
    Comp: $739.44k
  • Mr. Eric Raymond Powers III (Age 54)
    J.D., Chief Legal Officer & Corp. Sec.
    Comp: $507.76k
  • Mr. Timothy Morey (Age 60)
    Chief Sales Officer
    Comp: $404.76k
  • Mr. Kyle Landrum (Age 37)
    Chief Production Officer
    Comp: $411.96k
  • Mr. Steven Mathew White (Age 49)
    Pres
  • Mr. Ryan Blust
    Interim CFO, Controller & Director of Financial Reporting
  • Ms. Joy Malivuk (Age 48)
    VP & Chief Accounting Officer
  • Mr. Nilyum Jhala
    Chief Technology Officer
  • Mr. Jason Barry Pernell (Age 45)
    Chief Information Officer
  • Ms. Christine Hersey
    Director of Investor Relations













TCNNF Stock - Frequently Asked Questions

Should I buy or sell Trulieve Cannabis stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trulieve Cannabis in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TCNNF shares.
View TCNNF analyst ratings
or view top-rated stocks.

What is Trulieve Cannabis' stock price forecast for 2023?

3 analysts have issued 1 year price targets for Trulieve Cannabis' shares. Their TCNNF share price forecasts range from $6.00 to $132.00. On average, they expect the company's stock price to reach $43.33 in the next twelve months. This suggests a possible upside of 611.5% from the stock's current price.
View analysts price targets for TCNNF
or view top-rated stocks among Wall Street analysts.

How have TCNNF shares performed in 2023?

Trulieve Cannabis' stock was trading at $7.57 on January 1st, 2023. Since then, TCNNF stock has decreased by 19.6% and is now trading at $6.09.
View the best growth stocks for 2023 here
.

Are investors shorting Trulieve Cannabis?

Trulieve Cannabis saw a decline in short interest in September. As of September 15th, there was short interest totaling 522,800 shares, a decline of 51.0% from the August 31st total of 1,067,900 shares. Based on an average daily trading volume, of 1,550,300 shares, the short-interest ratio is presently 0.3 days.
View Trulieve Cannabis' Short Interest
.

When is Trulieve Cannabis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our TCNNF earnings forecast
.

How were Trulieve Cannabis' earnings last quarter?

Trulieve Cannabis Corp. (OTCMKTS:TCNNF) posted its quarterly earnings results on Monday, November, 15th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.27 by $0.13.

What is Trulieve Cannabis' stock symbol?

Trulieve Cannabis trades on the OTCMKTS under the ticker symbol "TCNNF."

How do I buy shares of Trulieve Cannabis?

Shares of TCNNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trulieve Cannabis' stock price today?

One share of TCNNF stock can currently be purchased for approximately $6.09.

How many employees does Trulieve Cannabis have?

The company employs 5,900 workers across the globe.

How can I contact Trulieve Cannabis?

Trulieve Cannabis' mailing address is 6749 Ben Bostic Road, Quincy, FL 32351. The official website for the company is www.trulieve.com. The company can be reached via phone at (850) 480-7955.

This page (OTCMKTS:TCNNF) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -